Fairness in cost-benefit analysis: A methodology for health technology assessment : Fairness in cost-benefit analysis
(2018) Health Economics — Vol. 27, n° 1, p. 102-114 (2018)
Files
Rep2957.pdf
Restricted Access - Adobe PDF
- 1008.09 KB
Details
- Authors
Samson, Anne-Laure 
- Abstract
- We evaluate the introduction of various forms of antihypertensive treatments in France with a distribution-sensitive cost-benefit analysis. Compared to traditional cost-benefit analysis, we implement distributional weighting based on equivalent incomes, a new concept of individual well-being that does respect individual preferences but is not subjectively welfarist. Individual preferences are estimated on the basis of a contingent valuation question, introduced into a representative survey of the French population. Compared to traditional cost-effectiveness analysis in health technology assessment, we show that it is feasible to go beyond a narrow evaluation of health outcomes while still fully exploiting the sophistication of medical information. Sensitivity analysis illustrates the relevancy of this richer welfare framework, the importance of the distribution between an ex ante and an ex post approach, and the need to consider distributional effects in a borader institutional setting.
- Affiliations
Citations
Samson, A.-L., Schokkaert, E., Thébaut, C., Dormont, B., Fleurbaey, M., Luchini, S., & Van de Voorde, C. (2018). Fairness in cost-benefit analysis: A methodology for health technology assessment : Fairness in cost-benefit analysis. Health Economics, 27(1), 102-114. https://doi.org/10.1002/hec.3515 (Original work published 2018)